EFPIARegulationPharma industry calls EU pharma package co...Pharmaceutical associations have responded with sharp criticism to the adoption of the revised general pharmaceutical legislation by the EU Council of Ministers in the form of a directive and a regulation. … more ➔
Bristol Myers SquibbPartnershipsSuper deal for BioNTech – BMS licenses p...In the race to replace MSD’s mega blockbuster pembrolizumab with a more effective bispecific VEGF x PD-(L)1 antibody, German company BioNTech SE has struck a good deal. BioNTech is now developing its … more ➔
Invest in Scotland, FlexBioEngineering biologyScotland’s bioeconomy gets scale-up boos...Scotland’s biotechnology sector is celebrating a major milestone with the launch of the nation’s first open-access 300-litre fermenter – a state-of-the-art piece of equipment that will support … more ➔
MichaelVi - stock.adobe.comColorectal cancerScientists uncover target to stop colitis-...German researchers have identified a promising new target to stop the inflammatory response in ulcerative colitis—a breakthrough that could help prevent the progression to colorectal cancer. Phase … more ➔
ECEuropean Commission EU set to improve investment for biotech...The European Commission has promised to create a new public-private fund to bridge the ‘valley of death’ phase for technology companies facing expansion. In addition, the EU wants to reduce its lag … more ➔
Norwegian Mycelium ASFermentationNorwegian Mycelium AS bags €1.25m to sca...Foodtech startup Norwegian Mycelium A/S has raised €1.25m in a financing round led by Nippon Beet Sugar Manufacturing Co., Ltd. (Nitten), Japan’s largest beet sugar producer, to scale-up its mycoprotein … more ➔
Adobe Stock - TechArtTrends Personalised medicineReproducible nanopore sequencing to be com...For nearly two decades, Roche AG has been searching for a next-generation sequencing method in personalised medicine to overcome the limitations of short read lengths in existing sequencing technologies. … more ➔
C4X DiscoveryDrug developmentC4X Discovery bags milestone for IL-17A b...C4X Discovery Holdings Ltd has received a €8m milestone payment from the French pharmaceutical company Sanofi for its preclinical IL-17A inhibitor. This payment is based on a licence agreement from … more ➔
Adobe Stock.com - BoontharikaGenetic engineeringNew way to target mitochondrial diseasesPharmacologists at the University of Göttingen, Germany, have reported a simple way to target and silence individual mitochondrial mRNAs in vivo. more ➔
SLASSLAS/AwardsBiopharma transformation: leading drug dis...British company Wildcat Laboratory Solutions Ltd and Hamburg-based mo:re GmbH have received the New Product Award from the Society for Laboratory Automation and Screening (SLAS) in recognition of new … more ➔
EFPIA
Bristol Myers Squibb
Invest in Scotland, FlexBio
MichaelVi - stock.adobe.com
EC
Norwegian Mycelium AS
Adobe Stock - TechArtTrends 
C4X Discovery
Adobe Stock.com - Boontharika
SLAS